Mitsubishi UFJ Trust & Banking’s Aurinia Pharmaceuticals AUPH Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$485K	Buy	+28,591	New	+$457K	﹤0.01%	1070

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's AUPH Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 28,591 shares worth $485K. The stake represents ﹤0.01% of the portfolio and ranks #1070 among its holdings.

281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 28,591 shares of Aurinia Pharmaceuticals worth $485K as of Q2 2026.
Aurinia Pharmaceuticals was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1070 holding.
281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.